StockSelector.com
  Research, Select, & Monitor Sunday, June 24, 2018 2:06:33 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Avadel Pharmaceuticals plc$6.27($.44)(6.56%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Avadel Pharmaceuticals plc has an overall rank of 541 out of 7142 stocks based on 10 positive rankings and 8 negative rankings.

Positive Rankings
PEGValue
Avadel Pharmaceuticals plc has a PEG Value of $210.00. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 3,249.28% in the next year. Among companies with a PEG Value above the current stock price, Avadel Pharmaceuticals plc is ranked 15.
Low vPut/Call
Avadel Pharmaceuticals plc has a low Put/Call ratio of 0.02 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Avadel Pharmaceuticals plc is ranked 49.
Highest ROE
Avadel Pharmaceuticals plc rank is 74
Highest ROA
Avadel Pharmaceuticals plc rank is 88
Historic Revenue Growth
Avadel Pharmaceuticals plc rank is 249
Highest Cash Growth
Avadel Pharmaceuticals plc rank is 362
Low Put/Call
Avadel Pharmaceuticals plc has a low Put/Call ratio of 0.14 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Avadel Pharmaceuticals plc is ranked 377.
SSValue
The StockSelector Value for Avadel Pharmaceuticals plc is $13.47. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Avadel Pharmaceuticals plc is ranked 464.
Oversold Stochastics
Avadel Pharmaceuticals plc rank is 578
Price-to-Sales
Avadel Pharmaceuticals plc rank is 2054
Negative Rankings
Negative EPS Growth
Avadel Pharmaceuticals plc rank is 129
10 Day Loss
Avadel Pharmaceuticals plc rank is 188
90 Day Loss
Avadel Pharmaceuticals plc rank is 442
Down EPS Surprise
Avadel Pharmaceuticals plc missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Net Margin
Avadel Pharmaceuticals plc rank is 1056
Debt-to-Equity
Avadel Pharmaceuticals plc rank is 1717
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Avadel Pharmaceuticals plc is ranked 1735.
Price-to-Book
Avadel Pharmaceuticals plc rank is 1846







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.